Journal of the American College of Cardiology

publication venue for

A worrisome interventricular septum: more than meets the eye. 2011
ACCF 2008 Training Statement on Multimodality Noninvasive Cardiovascular Imaging A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training Developed in Collaboration With the American Society of Echocardiography, the American Society of Nuclear Cardiology, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society for Vascular Medicine. 2009
Dyspnea in a patient with a prosthetic mitral valve. 2005
ACC/AHA clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence. 2003
Echocardiography in emergency medicine: a policy statement by the American Society of Echocardiography and the American College of Cardiology. Task Force on Echocardiography in Emergency Medicine of the American Society of Echocardiography and the Echocardiography and Technology and Practice Executive Committees of the American College of Cardiology. 1999
Variation in Health Status With Invasive vs Conservative Management of Chronic Coronary Disease.. 83. 2024
Effect of CSL112 on Recurrent Myocardial Infarction and Cardiovascular Death: Insights from the AEGIS-II Trial. 2024
Incidence, Predictors, and Impact of Hospital Readmission After Revascularization for Left Main Coronary Disease.. 83. 2024
Intraoperative Anemia Mediates Sex Disparity in Operative Mortality After Coronary Artery Bypass Grafting.. 83. 2024
Contemporary Management and Outcomes of Patients With High-Risk Pulmonary Embolism.. 83. 2024
Reporting Extended Follow-Up in Cardiovascular Clinical Trials.. 82. 2023
Sleep-Related Hypoxia, Right Ventricular Dysfunction, and Survival in Patients With Group 1 Pulmonary Arterial Hypertension.. 82. 2023
Outcomes According to Coronary Revascularization Modality in the ISCHEMIA Trial. 2023
Risk of Type B Dissection in Marfan Syndrome: The Cornell Aortic Aneurysm Registry. 2023
Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device.. 82. 2023
Impact of Malnutrition in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial.. 82. 2023
Reconsidering the Direction of Coronary Revascularization Trials.. 81. 2023
Low Utilization of Lead Extraction Among Patients With Infective Endocarditis and Implanted Cardiac Electronic Devices.. 81. 2023
Prevalence and Complications of Aberrant Subclavian Artery in Patients With Heritable and Nonheritable Arteriopathies.. 81. 2023
Cardiac Damage and Quality of Life After Aortic Valve Replacement in the PARTNER Trials.. 81. 2023
Vein Graft Use and Long-Term Survival Following Coronary Bypass Grafting.. 81. 2023
Incidence of Atherosclerotic Cardiovascular Disease in Young Adults at Low Short-Term But High Long-Term Risk.. 81. 2023
Race-Dependent Association of High-Density Lipoprotein Cholesterol Levels With Incident Coronary Artery Disease.. 80. 2022
Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT Trial.. 80. 2022
Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes.. 80. 2022
Impediments to Heart Transplantation in Adults With MELAS^{MT-TL1:m.3243A>G} Cardiomyopathy.. 80. 2022
Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease.. 80. 2022
Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard Protocols.. 79. 2022
Cardiovascular Outcomes in Aortopathy: GenTAC Registry of Genetically Triggered Aortic Aneurysms and Related Conditions.. 79. 2022
Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve Replacement.. 80. 2022
Outcomes Associated With Peripheral Artery Disease in Myocardial Infarction With Cardiogenic Shock.. 79. 2022
Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation.. 79. 2022
Life Expectancy After Surgical Aortic Valve Replacement.. 78. 2021
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk.. 78. 2021
Pregnancy-Related Aortic Complications in Women With Marfan Syndrome.. 78. 2021
Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.. 78. 2021
Global Prevalence and Impact of Hostility, Discrimination, and Harassment in the Cardiology Workplace.. 77. 2021
Permanent Pacemaker Implantation Following Valve-in-Valve Transcatheter Aortic Valve Replacement: VIVID Registry.. 77. 2021
Mitral Surgery After Transcatheter Edge-to-Edge Repair: Society of Thoracic Surgeons Database Analysis.. 78. 2021
COVID-19 in Adults With Congenital Heart Disease.. 77. 2021
Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.. 77. 2021
Association of Age With 10-Year Outcomes After Coronary Surgery in the Arterial Revascularization Trial.. 77. 2021
Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry.. 76. 2020
Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial.. 76. 2020
Characterization of Myocardial Injury in Patients With COVID-19.. 76. 2020
Prognostic Utility of Right Ventricular Remodeling Over Conventional Risk Stratification in Patients With COVID-19.. 76. 2020
Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization.. 76. 2020
Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial.. 76. 2020
Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease.. 76. 2020
Survival and Right Ventricular Function After Surgical Management of Acute Pulmonary Embolism.. 76. 2020
Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI.. 76. 2020
Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves: PARTNER 3 Cardiac Computed Tomography Substudy.. 75. 2020
The Impact of COVID-19 on Cardiovascular Training Programs: Challenges, Responsibilities, and Opportunities.. 76. 2020
Survival of Patients With Angina Pectoris Undergoing Percutaneous Coronary Intervention With Intracoronary Pressure Wire Guidance.. 75. 2020
The Consequences of the COVID-19 Pandemic on Non-COVID-19 Clinical Trials.. 76. 2020
Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes: The ODYSSEY OUTCOMES Trial.. 75. 2020
Long-Term Outcomes in Women and Men Following Percutaneous Coronary Intervention.. 75. 2020
The NCDR Left Atrial Appendage Occlusion Registry.. 75. 2020
Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis.. 75. 2020
Coronary Artery Target Selection and Survival After Bilateral Internal Thoracic Artery Grafting.. 75. 2020
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome.. 75. 2020
Risk of Mortality Following Catheter Ablation of Atrial Fibrillation.. 74. 2019
2019 ACC Health Policy Statement on Cardiologist Compensation and Opportunity Equity.. 74. 2019
Multiple Versus Single Arterial Coronary Bypass Graft Surgery for Multivessel Disease.. 74. 2019
Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery.. 74. 2019
Off-Pump Versus On-Pump Bypass Surgery for Left Main Coronary Artery Disease.. 74. 2019
Burnout and Career Satisfaction Among U.S. Cardiologists.. 73. 2019
Effect of Calcium-Channel Blocker Therapy on Radial Artery Grafts After Coronary Bypass Surgery.. 73. 2019
Dietary Patterns and Incident Heart Failure in U.S. Adults Without Known Coronary Disease.. 73. 2019
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial.. 74. 2019
Academic Advancement in the Current Era: Integrating and Empowering Clinician Educators.. 73. 2019
Differences in Risk of Sudden Cardiac Death Between Blacks and Whites.. 72. 2018
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial.. 73. 2018
Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS.. 72. 2018
2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk.. 72. 2018
Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease.. 72. 2018
Myocardial Fibrosis in Patients With Primary Mitral Regurgitation With and Without Prolapse.. 72. 2018
Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.. 72. 2018
1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification.. 71. 2018
Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United States.. 71. 2018
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.. 71. 2018
Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension.. 71. 2018
New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.. 71. 2018
Agreement of the Resting Distal to Aortic Coronary Pressure With the Instantaneous Wave-Free Ratio.. 70. 2017
Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI.. 70. 2017
Transcatheter Mitral Valve Replacement for Degenerated Bioprosthetic Valves and Failed Annuloplasty Rings.. 70. 2017
Risk of Arterial Thromboembolism in Patients With Cancer.. 70. 2017
Angiotensin-Converting Enzyme Inhibition Early After Heart Transplantation.. 69. 2017
Marfan Syndrome and Quality of Life in the GenTAC Registry.. 69. 2017
Estimating Left Ventricular Filling Pressure by Echocardiography.. 69. 2017
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis.. 69. 2017
Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against β₁-Adrenergic Receptors.. 69. 2017
The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.. 69. 2017
SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial.. 69. 2017
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.. 69. 2017
Transcatheter Mitral Valve Replacement for Patients With Symptomatic Mitral Regurgitation: A Global Feasibility Trial.. 69. 2016
Bleeding Events Before Coronary Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.. 68. 2016
Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement.. 69. 2016
Prediction of Poor Outcome After Transcatheter Aortic Valve Replacement.. 68. 2016
52 Genetic Loci Influencing Myocardial Mass.. 68. 2016
Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics.. 68. 2016
Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI.. 68. 2016
2016 ACC/ASE/ASNC/HRS/SCAI Health Policy Statement on Integrating the Healthcare Enterprise.. 68. 2016
Underutilization of Coronary Artery Disease Testing Among Patients Hospitalized With New-Onset Heart Failure.. 68. 2016
Predicting Early and Late Mortality After Transcatheter Aortic Valve Replacement.. 68. 2016
Aortic Dissection in Patients With Genetically Mediated Aneurysms: Incidence and Predictors in the GenTAC Registry.. 67. 2016
Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial.. 67. 2016
Intratracheal Gene Delivery of SERCA2a Ameliorates Chronic Post-Capillary Pulmonary Hypertension: A Large Animal Model.. 67. 2016
The Prognostic Value of Residual Coronary Stenoses After Functionally Complete Revascularization.. 67. 2016
3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement.. 67. 2016
Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement.. 67. 2016
Enhanced Cardiac Regenerative Ability of Stem Cells After Ischemia-Reperfusion Injury: Role of Human CD34+ Cells Deficient in MicroRNA-377.. 66. 2015
CABG Versus PCI: Greater Benefit in Long-Term Outcomes With Multiple Arterial Bypass Grafting.. 66. 2015
2-Year Outcomes After Iliofemoral Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery.. 66. 2015
2-Year Outcomes in Patients Undergoing Surgical or Self-Expanding Transcatheter Aortic Valve Replacement.. 66. 2015
Hospital length of stay and clinical outcomes in older STEMI patients after primary PCI: a report from the National Cardiovascular Data Registry.. 65. 2015
Task Force 3: Pediatric Cardiology Fellowship Training in Cardiac Catheterization.. 66. 2015
Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO study.. 65. 2015
Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease.. 65. 2015
Association of immature platelets with adverse cardiovascular outcomes.. 64. 2014
Cor pulmonale parvus in chronic obstructive pulmonary disease and emphysema: the MESA COPD study.. 64. 2014
The relationship of left ventricular trabeculation to ventricular function and structure over a 9.5-year follow-up: the MESA study.. 64. 2014
Echocardiographic Evaluation of Hemodynamics in Patients With Systolic Heart Failure Supported by a Continuous-Flow LVAD.. 64. 2014
Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology.. 64. 2014
AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and U.S. Department of Health and Human Services.. 64. 2014
High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain: results from the ROMICAT-II trial.. 64. 2014
Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium.. 64. 2014
SCAI/AATS/ACC/STS operator and institutional requirements for transcatheter valve repair and replacement. Part II. mitral valve.. 64. 2014
Appropriateness of primary prevention implantable cardioverter-defibrillators at the time of generator replacement: are indications still met?. 63. 2014
Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.. 63. 2014
Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).. 63. 2014
Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: results from the REGARDS Study (REasons for Geographic And Racial Differences in Stroke).. 63. 2014
Ethanol infusion in the vein of Marshall leads to parasympathetic denervation of the human left atrium: implications for atrial fibrillation.. 63. 2014
Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS.. 63. 2014
Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial.. 63. 2014
Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.. 63. 2014
Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).. 63. 2013
The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation.. 62. 2013
Earlier arterial switch operation improves outcomes and reduces costs for neonates with transposition of the great arteries.. 63. 2013
Impact of intraprocedural stent thrombosis during percutaneous coronary intervention: insights from the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary Intervention).. 63. 2013
Moving from political declaration to action on reducing the global burden of cardiovascular diseases: a statement from the Global Cardiovascular Disease Taskforce.. 62. 2013
Alternative ankle-brachial index method identifies additional at-risk individuals.. 62. 2013
Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the U.S. PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve).. 62. 2013
Subtle post-procedural cognitive dysfunction after atrial fibrillation ablation.. 62. 2013
Effects of bariatric surgery on human small artery function: evidence for reduction in perivascular adipocyte inflammation, and the restoration of normal anticontractile activity despite persistent obesity.. 62. 2013
Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention?. 61. 2013
Safety and feasibility of robotic percutaneous coronary intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) Study.. 61. 2013
Nonsystem reasons for delay in door-to-balloon time and associated in-hospital mortality: a report from the National Cardiovascular Data Registry.. 61. 2013
The heart team of cardiovascular care.. 61. 2013
ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance.. 61. 2013
Appropriate use of cardiovascular technology: 2013 ACCF appropriate use criteria methodology update: a report of the American College of Cardiology Foundation appropriate use criteria task force.. 61. 2013
2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on clinical data standards (writing committee to develop acute coronary syndromes and coronary artery disease clinical data standards).. 61. 2013
President's page: A new year, a new venue: let's take our hearts to San Francisco.. 61. 2013
Behavioral mechanisms, elevated depressive symptoms, and the risk for myocardial infarction or death in individuals with coronary heart disease: the REGARDS (Reason for Geographic and Racial Differences in Stroke) study.. 61. 2013
The prevalence and outcomes of transradial percutaneous coronary intervention for ST-segment elevation myocardial infarction: analysis from the National Cardiovascular Data Registry (2007 to 2011).. 61. 2012
ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.. 61. 2012
Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer.. 60. 2012
President's page: the ACC: taking on congenital heart disease and winning!. 60. 2012
Prospective, Randomized, Multicenter Evaluation of a Polyethylene Terephthalate Micronet Mesh-Covered Stent (MGuard) in ST-Segment Elevation Myocardial Infarction: The MASTER Trial.. 60. 2012
Quantitative expression of the mutated lamin A/C gene in patients with cardiolaminopathy.. 60. 2012
Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study.. 60. 2012
Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke).. 60. 2012
Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial.. 60. 2012
Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation.. 60. 2012
Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI Registry.. 59. 2012
Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial.. 59. 2012
Intraprocedural thrombotic events during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes are associated with adverse outcomes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.. 59. 2012
Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis: the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study.. 59. 2012
Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry.. 58. 2011
Factors associated with subsequent arch reintervention after initial balloon aortoplasty in patients with Norwood procedure and arch obstruction.. 58. 2011
Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.. 58. 2011
Aortic expansion rate in patients with dilated post-stenotic ascending aorta submitted only to aortic valve replacement long-term follow-up.. 58. 2011
Mortality risk in symptomatic patients with nonobstructive coronary artery disease: a prospective 2-center study of 2,583 patients undergoing 64-detector row coronary computed tomographic angiography.. 58. 2011
Imaging of the aortic valve using fluorodeoxyglucose positron emission tomography increased valvular fluorodeoxyglucose uptake in aortic stenosis.. 57. 2011
Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).. 57. 2011
The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) trial: results of the continuous electrocardiographic assessment substudy.. 57. 2011
Positron emission tomography measurement of periodontal 18F-fluorodeoxyglucose uptake is associated with histologically determined carotid plaque inflammation.. 57. 2011
β-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure.. 57. 2011
Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).. 57. 2011
Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial.. 57. 2010
Iodofiltic acid I 123 (BMIPP) fatty acid imaging improves initial diagnosis in emergency department patients with suspected acute coronary syndromes: a multicenter trial.. 56. 2010
Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.. 56. 2010
Cardiovascular events during differing hypertension therapies in patients with diabetes.. 56. 2010
Common functional genetic variants in catecholamine storage vesicle protein promoter motifs interact to trigger systemic hypertension.. 55. 2010
Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the "warranty period" for remaining normal?. 55. 2010
A multicenter assessment of the use of single-photon emission computed tomography myocardial perfusion imaging with appropriateness criteria.. 55. 2010
Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation.. 55. 2010
A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.. 54. 2009
Stent gap by 64-detector computed tomographic angiography relationship to in-stent restenosis, fracture, and overlap failure.. 54. 2009
Normal stress-only versus standard stress/rest myocardial perfusion imaging: similar patient mortality with reduced radiation exposure.. 55. 2009
The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk.. 54. 2009
High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study.. 54. 2009
Delayed untwisting: the mechanistic link between dynamic obstruction and exercise tolerance in patients with hypertrophic obstructive cardiomyopathy.. 54. 2009
Neuropeptide Y(1) Receptor NPY1R discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo.. 54. 2009
Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association's Get With The Guidelines Program.. 54. 2009
Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.. 54. 2009
Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry.. 53. 2009
Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial.. 53. 2009
Real-time 3-dimensional transesophageal echocardiography in the evaluation of post-operative mitral annuloplasty ring and prosthetic valve dehiscence.. 53. 2009
Ambulatory monitoring of congestive heart failure by multiple bioelectric impedance vectors.. 53. 2009
Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort.. 53. 2009
Effect of physician volume on the relationship between hospital volume and mortality during primary angioplasty.. 53. 2009
The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.. 53. 2009
Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.. 52. 2008
Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.. 52. 2008
Naturally occurring human genetic variation in the 3'-untranslated region of the secretory protein chromogranin A is associated with autonomic blood pressure regulation and hypertension in a sex-dependent fashion.. 52. 2008
Localization of atrial fibrillation triggers in patients undergoing pulmonary vein isolation: importance of the carina region.. 52. 2008
Long-term impact of drug-eluting stents versus bare-metal stents on all-cause mortality.. 52. 2008
Cardiac markers of pre-clinical disease in adolescents with the metabolic syndrome: the strong heart study.. 52. 2008
Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.. 52. 2008
Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction.. 52. 2008
Survival and clinical course at Fontan after stage one palliation with either a modified Blalock-Taussig shunt or a right ventricle to pulmonary artery conduit.. 52. 2008
Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study.. 51. 2008
Cockcroft-Gault versus modification of diet in renal disease: importance of glomerular filtration rate formula for classification of chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes.. 51. 2008
A novel feature-tracking echocardiographic method for the quantitation of regional myocardial function: validation in an animal model of ischemia-reperfusion.. 51. 2008
Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.. 50. 2007
Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial.. 50. 2007
Supine bicycle echocardiography improved diagnostic accuracy and physiologic assessment of coronary artery disease with the incorporation of intermediate stages of exercise.. 50. 2007
Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality.. 50. 2007
Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project.. 50. 2007
Outcome of surgical myectomy after unsuccessful alcohol septal ablation for the treatment of patients with hypertrophic obstructive cardiomyopathy.. 50. 2007
Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction.. 50. 2007
Results of the U.S. multicenter pivotal study of the HELEX septal occluder for percutaneous closure of secundum atrial septal defects.. 49. 2007
Clinical and electrophysiological spectrum of idiopathic ventricular outflow tract arrhythmias.. 49. 2007
Adenosine-insensitive focal atrial tachycardia: evidence for de novo micro-re-entry in the human atrium.. 49. 2007
Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury.. 49. 2007
In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting?. 49. 2007
Aortic root translocation plus arterial switch for transposition of the great arteries with left ventricular outflow tract obstruction: intermediate-term results.. 49. 2007
A multinational study to establish the value of early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low-risk group for early hospital discharge after acute myocardial infarction.. 48. 2006
An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction.. 48. 2006
Endothelial progenitor cells participate in nicotine-mediated angiogenesis.. 48. 2006
Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study.. 48. 2006
Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.. 48. 2006
Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study.. 47. 2006
The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.. 47. 2006
Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement.. 47. 2006
Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging.. 47. 2006
A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes.. 47. 2006
Initial experience with a magnetic navigation system for percutaneous coronary intervention in complex coronary artery lesions.. 47. 2006
Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes.. 47. 2006
Risk stratification of in-hospital mortality for coronary artery bypass graft surgery.. 47. 2006
Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.. 47. 2005
Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging.. 46. 2005
The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study.. 46. 2005
Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials.. 46. 2005
Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial.. 45. 2005
C-reactive protein and electrocardiographic ST-segment depression additively predict mortality: the Strong Heart Study.. 45. 2005
Effects of left ventricular assist device therapy on ventricular arrhythmias.. 45. 2005
A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis.. 45. 2005
Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure.. 45. 2005
Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial.. 45. 2005
Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial.. 45. 2005
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.. 45. 2005
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.. 45. 2005
Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.. 45. 2005
Migraine headache relief after transcatheter closure of patent foramen ovale.. 45. 2005
Intravascular ultrasound-guided treatment for angiographically indeterminate left main coronary artery disease: a long-term follow-up study.. 45. 2005
Clinical prediction rule for atrial fibrillation after coronary artery bypass grafting.. 44. 2004
Effects of a novel immune modulation therapy in patients with advanced chronic heart failure: results of a randomized, controlled, phase II trial.. 44. 2004
Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy.. 44. 2004
Myocardial ischemia and infarction.. 44. 2004
Working group 4: International medical graduates and the cardiology workforce.. 44. 2004
Left atrial structure and function after percutaneous left atrial appendage transcatheter occlusion (PLAATO): six-month echocardiographic follow-up.. 43. 2004
Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry.. 43. 2004
Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction.. 43. 2004
Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry.. 43. 2004
Aspirin dose and six-month outcome after an acute coronary syndrome.. 43. 2004
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study.. 43. 2004
Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices.. 43. 2004
A comparison of short- and long-term outcomes after off-pump and on-pump coronary artery bypass graft surgery with sternotomy.. 43. 2004
Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction.. 43. 2004
Transesophageal echocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: results of the international PRO-TEE registry.. 43. 2004
Phospholipid abnormalities in children with Barth syndrome.. 42. 2003
A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina.. 42. 2003
Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial.. 42. 2003
Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial.. 42. 2003
Time interval between onset of mitral inflow and onset of early diastolic velocity by tissue Doppler: a novel index of left ventricular relaxation: experimental studies and clinical application.. 42. 2003
Age does not limit quality of life improvement in cardiac valve surgery.. 42. 2003
Competing autonomic mechanisms precede the onset of postoperative atrial fibrillation.. 42. 2003
A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study.. 42. 2003
Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy.. 42. 2003
Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure.. 42. 2003
Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study.. 41. 2003
Poverty, process of care, and outcome in acute coronary syndromes.. 41. 2003
Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial.. 41. 2003
Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension.. 41. 2003
Nicotine promotes arteriogenesis.. 41. 2003
Relationship between heparin anticoagulation and clinical outcomes in coronary stent intervention: observations from the ESPRIT trial.. 41. 2003
Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients.. 41. 2003
Release of matrix metalloproteinases following alcohol septal ablation in hypertrophic obstructive cardiomyopathy.. 40. 2002
Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality.. 40. 2002
Quantitative assessment of electrocardiographic strain predicts increased left ventricular mass: the Strong Heart Study.. 40. 2002
Cardiovascular remodeling is greater in isolated systolic hypertension than in diastolic hypertension in older adults: the Insufficienza Cardiaca negli Anziani Residenti (ICARE) a Dicomano Study.. 40. 2002
Homocysteine impairs coronary microvascular dilator function in humans.. 40. 2002
Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention?. Lessons from the ESPRIT study.. 40. 2002
Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes.. 40. 2002
Percutaneous coronary interventions in octogenarians in the American College of Cardiology-National Cardiovascular Data Registry: development of a nomogram predictive of in-hospital mortality.. 40. 2002
Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients?. 40. 2002
Lesional tachycardias related to mitral valve surgery.. 39. 2002
Prognostic significance of left ventricular diastolic dysfunction in essential hypertension.. 39. 2002
Active interstitial remodeling: an important process in the hibernating human myocardium.. 39. 2002
Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial.. 39. 2002
American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee).. 38. 2001
Absence of gender differences in clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction. A report from the SHOCK Trial Registry.. 38. 2001
Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices.. 38. 2001
Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point.. 38. 2001
Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up.. 38. 2001
Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine.. 38. 2001
Physical training in patients with chronic heart failure enhances the expression of genes encoding antioxidative enzymes.. 38. 2001
Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network.. 38. 2001
The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study.. 37. 2001
Real-time assessment of myocardial perfusion and wall motion during bicycle and treadmill exercise echocardiography: comparison with single photon emission computed tomography.. 37. 2001
Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators.. 37. 2001
Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy.. 37. 2001
Hemodynamic determinants of the mitral annulus diastolic velocities by tissue Doppler.. 37. 2001
An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes.. 36. 2000
Obstacle-induced transition from ventricular fibrillation to tachycardia in isolated swine right ventricles: insights into the transition dynamics and implications for the critical mass.. 36. 2000
Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy.. 36. 2000
Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?. 36. 2000
Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up.. 36. 2000
Relation of tissue Doppler derived myocardial velocities to myocardial structure and beta-adrenergic receptor density in humans.. 36. 2000
Prevalence and correlates of aortic regurgitation in American Indians: the Strong Heart Study.. 36. 2000
Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina.. 36. 2000
Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction.. 35. 2000
End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: relation to rest-redistribution T1-201 tomography and dobutamine stress echocardiography.. 35. 2000
The future of cardiology: utilization and costs of care.. 35. 2000
Does coronary angiography before emergency aortic surgery affect in-hospital mortality?. 35. 2000
The future of cardiology: utilization and costs of care.. 35. 2000
Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study.. 35. 2000
Comparison of a novel rectilinear biphasic waveform with a damped sine wave monophasic waveform for transthoracic ventricular defibrillation. ZOLL Investigators.. 34. 1999
Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement.. 34. 1999
Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.. 34. 1999
Gene transfer of nitric oxide synthase: effects on endothelial biology.. 34. 1999
Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era.. 34. 1999
Supine bicycle versus post-treadmill exercise echocardiography in the detection of myocardial ischemia: a randomized single-blind crossover trial.. 33. 1999
Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction.. 33. 1999
Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile.. 33. 1999
A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty.. 33. 1999
Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty.. 33. 1999
Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG Investigators. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation of PTCA To Improve Long-term Outcome with abciximab GPIIb/IIIa Receptor Blockade.. 32. 1998
Association of chronotropic incompetence with echocardiographic ischemia and prognosis.. 32. 1998
Differentiating thrombus from pannus formation in obstructed mechanical prosthetic valves: an evaluation of clinical, transthoracic and transesophageal echocardiographic parameters.. 32. 1998
Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction.. 32. 1998
Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions.. 32. 1998
Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries.. 32. 1998
Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Study Group.. 32. 1998
Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.. 32. 1998
Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. EPIC Investigators. Evaluation of IIb/IIIa Platelet Receptor Antagonist 7E3 in Preventing Ischemic Complications.. 31. 1998
Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures.. 30. 1997
Serial changes in response of hibernating myocardium to inotropic stimulation after revascularization: a dobutamine echocardiographic study.. 30. 1997
Pathologic correlates of aortic plaques, thrombi and mobile "aortic debris" imaged in vivo with transesophageal echocardiography.. 30. 1997
Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. EPIC Investigators. Evaluation of 7E3 in Preventing Ischemic Complications.. 30. 1997
Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia.. 30. 1997
Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction.. 30. 1997
Association of angiotensin I-converting enzyme gene polymorphism with myocardial ischemia and patency of infarct-related artery in patients with acute myocardial infarction.. 29. 1997
Relation between clinical, angiographic and ischemic findings at baseline and ischemia-related adverse outcomes at 1 year in the Asymptomatic Cardiac Ischemia Pilot study. ACIP Study Group.. 29. 1997
Adenosine thallium-201 tomography in evaluation of graft patency late after coronary artery bypass graft surgery.. 29. 1997
Relation of hemodynamic volume load to arterial and cardiac size.. 29. 1997
Identification of hibernating myocardium: comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography.. 29. 1997
Relation between ambulatory electrocardiographic monitoring and myocardial perfusion imaging to detect coronary artery disease and myocardial ischemia: an ACIP ancillary study. The Asymptomatic Cardiac Ischemia Pilot (ACIP) Investigators.. 29. 1997
Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans.. 29. 1997
Comparison of early and recent results with rotational atherectomy.. 29. 1997
Cardiovascular effects of exercise: role of endothelial shear stress.. 28. 1996
Effect of managed care on cardiovascular specialists: involvement, attitudes and practice adaptations.. 28. 1996
Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits.. 28. 1996
QT interval-heart rate relation during exercise in normal men and women: definition by linear regression analysis.. 28. 1996
Detection of left anterior descending coronary artery stenosis in patients with left bundle branch block: exercise, adenosine or dobutamine imaging?. 28. 1996
Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults.. 28. 1996
Prognostic value of heart rate adjustment of exercise-induced ST segment depression in the multiple risk factor intervention trial.. 27. 1996
Posterior fast atrioventricular node pathways: implications for radiofrequency catheter ablation of atrioventricular node reentrant tachycardia.. 27. 1996
Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).. 27. 1996
Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty.. 27. 1996
Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity.. 27. 1996
Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GPIIb/IIIa receptors.. 26. 1995
Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival.. 26. 1995
Asymptomatic Cardiac Ischemia Pilot (ACIP) study: effects of coronary angioplasty and coronary artery bypass graft surgery on recurrent angina and ischemia. The ACIP investigators.. 26. 1995
Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. The ACIP Investigators.. 26. 1995
Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.. 26. 1995
Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz Stent Study Group.. 26. 1995
Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis.. 26. 1995
Myocardial contrast echocardiography: relation of collateral perfusion to extent of injury and severity of contractile dysfunction in a canine model of coronary thrombosis and reperfusion.. 26. 1995
Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients.. 26. 1995
Simultaneous assessment of myocardial perfusion and left ventricular function during transient coronary occlusion.. 25. 1995
Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction.. 25. 1995
Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk.. 25. 1995
Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products.. 25. 1995
Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction.. 25. 1995
Association of carotid atherosclerosis and left ventricular hypertrophy.. 25. 1995
Pseudoaneurysms of the mitral-aortic intervalvular fibrosa: dynamic characterization using transesophageal echocardiographic and Doppler techniques.. 25. 1995
Risk stratification for arrhythmic events in patients with nonischemic dilated cardiomyopathy and nonsustained ventricular tachycardia: role of programmed ventricular stimulation and the signal-averaged electrocardiogram.. 24. 1994
Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia: results of a double-blind, placebo-controlled trial using quantitative thallium-201 tomography.. 24. 1994
Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension.. 23. 1994
Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators.. 23. 1994
A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.. 23. 1994
Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group.. 23. 1994
Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit.. 23. 1994
Electrocardiographic diagnosis of left ventricular hypertrophy by the time-voltage integral of the QRS complex.. 23. 1994
Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects.. 22. 1993
Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trial.. 22. 1993
Prognostic significance of the pattern of aortic root dilation in the Marfan syndrome.. 22. 1993
Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. The SOLVD Investigators.. 22. 1993
Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot Study.. 22. 1993
Measurement variables for optimal performance of the ST integral.. 22. 1993
Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing.. 21. 1993
Effects of acute, transient coronary occlusion on global and regional right ventricular function in humans.. 20. 1992
Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product.. 20. 1992
Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.. 20. 1992
Equivalence between adenosine and exercise thallium-201 myocardial tomography: a multicenter, prospective, crossover trial.. 20. 1992
Transesophageal echocardiography. American College of Cardiology position statement.. 20. 1992
Estimation of left ventricular end-diastolic pressure from Doppler transmitral flow velocity in cardiac patients independent of systolic performance.. 20. 1992
Heparin-induced prolongation of partial thromboplastin time after thrombolysis: relation to coronary artery patency. HART Investigators.. 20. 1992
Effects of diltiazem on recurrent myocardial infarction in patients with non-Q wave myocardial infarction.. 19. 1992
Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension.. 19. 1992
Confronting the issues of patient safety and investigator conflict of interest in an international clinical trial of myocardial reperfusion. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO) Steering Committee.. 19. 1992
Hyperlipidemia after heart transplantation: report of a 6-year experience, with treatment recommendations.. 19. 1992
Relation of perfusion defects observed with myocardial contrast echocardiography to the severity of coronary stenosis: correlation with thallium-201 single-photon emission tomography.. 19. 1992
Adenosine-induced atrioventricular block: a rapid and reliable method to assess surgical and radiofrequency catheter ablation of accessory atrioventricular pathways.. 19. 1992
Association of aortic dilation with regurgitant, stenotic and functionally normal bicuspid aortic valves.. 19. 1992
Quantification of left ventricular performance during transient coronary occlusion at various anatomic sites in humans: a study using tantalum-178 and a multiwire gamma camera.. 19. 1992
Heart rate adjustment of the time-voltage ST segment integral: identification of coronary disease and relation to standard and heart rate-adjusted ST segment depression criteria.. 18. 1991
Diagnosis of ischemic heart disease with adenosine echocardiography.. 18. 1991
Lipoprotein(a) and apolipoprotein changes after cardiac transplantation.. 18. 1991
Quantitative thallium-201 single-photon emission computed tomography during maximal pharmacologic coronary vasodilation with adenosine for assessing coronary artery disease.. 18. 1991
Tolerance and safety of pharmacologic coronary vasodilation with adenosine in association with thallium-201 scintigraphy in patients with suspected coronary artery disease.. 18. 1991
Criteria for the accurate interpretation of changes in left ventricular ejection fraction and cardiac volumes as assessed by rest and exercise gated radionuclide angiography.. 18. 1991
Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in patients surviving open label titration but not randomized to double-blind therapy.. 18. 1991
Normalization of left ventricular mass and associated changes in neurohormones and atrial natriuretic peptide after 1 year of sustained nifedipine therapy for severe hypertension.. 17. 1991
Effects of prolonged transesophageal echocardiographic imaging and probe manipulation on the esophagus--an echocardiographic-pathologic study.. 17. 1991
Factors determining improvement in left ventricular function after reperfusion therapy for acute myocardial infarction: primacy of baseline ejection fraction.. 17. 1991
The automatic implantable cardioverter-defibrillator: effect of patch polarity on defibrillation threshold.. 17. 1991
The variable extent of jeopardized myocardium in patients with single vessel coronary artery disease: quantification by thallium-201 single photon emission computed tomography.. 17. 1991
Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results.. 16. 1990
The signal-averaged electrocardiogram and ventricular arrhythmias after thrombolysis for acute myocardial infarction.. 15. 1990
Day-to-day variability of voltage measurements used in electrocardiographic criteria for left ventricular hypertrophy.. 15. 1990
Determination of left ventricular volumes with use of a new nongeometric echocardiographic method: clinical validation and potential application.. 15. 1990
Quantitative exercise thallium-201 single photon emission computed tomography for the enhanced diagnosis of ischemic heart disease.. 15. 1990
Assessment of regional myocardial perfusion by contrast echocardiography. II. Detection of changes in transmural and subendocardial perfusion during dipyridamole-induced hyperemia in a model of critical coronary stenosis.. 14. 1989
Determinants of abnormal left ventricular filling in early hypertension.. 14. 1989
Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy.. 14. 1989
Plasma atrial natriuretic factor in essential hypertension: relation to cardiac size, function and systemic hemodynamics.. 14. 1989
Left ventricular diastolic dysfunction: early diastolic relaxation and late diastolic compliance.. 13. 1989
The St. Jude valve prosthesis: analysis of the clinical results in 815 implants and the need for systemic anticoagulation.. 13. 1989
Mitral valve dimensions and motion and familial transmission of mitral valve prolapse with and without mitral leaflet billowing.. 12. 1988
Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile.. 12. 1988
Current-based versus energy-based ventricular defibrillation: a prospective study.. 12. 1988
Reversal of chronic ischemic myocardial dysfunction after transluminal coronary angioplasty.. 12. 1988
Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults.. 12. 1988
Left ventricular mass in children and adolescents.. 12. 1988
Clinical significance of perfusion defects by thallium-201 single photon emission tomography following oral dipyridamole early after coronary angioplasty.. 11. 1988
Quantitative thallium-201 single photon emission computed tomography after oral dipyridamole for assessing the presence, anatomic location and severity of coronary artery disease.. 11. 1988
Surgical treatment of right atrial focal tachycardia in adults.. 11. 1988
Assessment of myocardial perfusion in humans by contrast echocardiography. I. Evaluation of regional coronary reserve by peak contrast intensity.. 11. 1988
Quantitative assessment of left ventricular wall motion by two-dimensional echocardiography: validation during reversible ischemia in the conscious dog.. 11. 1988
End-systolic radius to thickness ratio: an echocardiographic index of regional performance during reversible myocardial ischemia in the conscious dog.. 10. 1987
Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects, efficacy and toxicity.. 9. 1987
Geometric and functional correlates of electrocardiographic repolarization and voltage abnormalities in aortic regurgitation.. 9. 1987
Doppler echocardiographic analysis of left ventricular filling in treated hypertensive patients.. 9. 1987
Gated blood pool scintigraphic monitoring of doxorubicin cardiomyopathy: comparison of camera and computerized probe results in 101 patients.. 8. 1986
Relation between clinical features of the mitral prolapse syndrome and echocardiographically documented mitral valve prolapse.. 8. 1986
Effects of recent and remote infarction on the predictive accuracy of the ST segment/heart rate slope.. 8. 1986
Determination of regurgitant fraction in isolated mitral or aortic regurgitation by pulsed Doppler two-dimensional echocardiography.. 7. 1986
The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension.. 7. 1986
Early infarct expansion: structural or functional?. 6. 1985
Sustained ventricular tachyarrhythmias within 2 months of acute myocardial infarction: results of medical and surgical therapy in patients resuscitated from the initial episode.. 6. 1985
Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria.. 6. 1985
Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias.. 6. 1985
Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects.. 5. 1985
Plasma epinephrine concentration in healthy men: correlation with systolic pressure and rate-pressure product.. 5. 1985
Standardization of M-mode echocardiographic left ventricular anatomic measurements.. 4. 1984
Comparison of two-dimensional echocardiography with gated radionuclide ventriculography in the evaluation of global and regional left ventricular function in acute myocardial infarction.. 3. 1984
Use of electrocardiographic-thallium exercise testing in clinical practice.. 3. 1984
Duration of ejection in aortic stenosis: effect of stroke volume and pressure gradient.. 3. 1984
Electrocardiographic detection of left ventricular hypertrophy using echocardiographic determination of left ventricular mass as the reference standard. Comparison of standard criteria, computer diagnosis and physician interpretation.. 3. 1984
Definition of the safe lower limits of aortic resection during surgical procedures on the thoracoabdominal aorta: use of somatosensory evoked potentials.. 2. 1983
Reply: Delivering Ethnic and Racial Diversity in Cardiac Imaging Studies of COVID-19 Patients.. 77. 2021
Surgeons' Coronary Bypass Practice Patterns in the United States.. 76. 2020
Effects of the COVID-19 Pandemic on Active Non-COVID Clinical Trials.. 76. 2020
The COVID-19 Pandemic and Acute Aortic Dissections in New York: A Matter of Public Health.. 76. 2020
Effect of Baseline Anemia on Outcomes After Left Main Coronary Revascularization.. 75. 2020
Operator Volume to Outcome Relationship in Mitral and Aortic Valve Replacement.. 74. 2019
Reply: Calcium-Channel Blockers in Patients With Radial Artery Grafts: Art Versus Science.. 74. 2019
Reply: Potential for Improving the Public Health Through Race and Sudden Cardiac Death Research.. 73. 2019
Reply: TAVR: Risk Models, Mortality Scoring, and Geriatric Assessment.. 69. 2017
Reply: Acute Radial Artery Injury After Instrumentation: Are Instrumented Radial Artery Conduits Ideal for CABG?. 68. 2016
Reply: Left Atrial Appendage Occlusion Device Societal Overview: The Surgeon's Comment.. 67. 2016
Left atrial thrombus formation after successful left atrial appendage ligation: case series from a nationwide survey.. 65. 2015
Reply: Differences in experience with a new delivery device for LAA ligation among various U.S. centers.. 65. 2015
Reply: Ejection fraction may improve but the scar still exists! The risk may be lower but not zero.. 64. 2014
Regarding the effect of dabigatran plasma concentrations.. 63. 2014
Atrioventricular valve annular remodeling with a bioabsorbable ring in young children.. 60. 2012
President's page: the ACC reconfirms commitment to transparent relationships with industry.. 56. 2010
Is appropriate use criteria for cardiac radionuclide imaging in asymptomatic diabetic patients evidence based?. 55. 2010
Multiple bioelectric impedance vectors in the monitoring of congestive heart failure.. 55. 2010
Is the relationship between beta-blocker-induced heart rate lowering and cardiovascular outcomes the result of confounding by indication?. 53. 2009
Early breast cancer therapy and cardiovascular injury.. 51. 2008
Assessing risk after acute myocardial infarction.. 49. 2007
Left ventricular systolic dysfunction in rheumatoid disease.. 48. 2006
Is the lower mortality in patients treated with aspirin and angiotensin-converting enzyme inhibitors due to decreased norepinephrine release?. 35. 2000
Selective ablation of slow atrioventricular node conduction pathways: how safe is the anatomic posterior approach?. 28. 1996
Coumadin and the St. Jude valve prosthesis.. 14. 1989
Renovascular disease in the elderly.. 7. 1986
Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. 2001
Etripamil Nasal Spray for Recurrent Paroxysmal Supraventricular Tachycardia Conversion: Results from the NODE-303 Open-label Study. 2024
Elevated C-Reactive Protein Amplifies Association of Lipoprotein(a) With Cardiovascular Risk and Clinical Benefit of Alirocumab. 2022
Implications of Biomarker Discordance After Coronary Artery Revascularization: The EXCEL Trial. 2021
Reply: Survival and RV Function After Surgical Management of Acute PE. 2020
Reply: Early Mortality Following Catheter Ablation of Atrial Fibrillation. 2020
Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY OUTCOMES. 2020
Asymptomatic Patients With Abnormal Fractional Flow Reserve Treated With Medication Alone or With PCI. 2019
Cardiovascular Biomarkers After Metabolic Surgery Versus Medical Therapy for Diabetes. 2019
Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting. 2018
Reply: Arterial Thromboembolism in Non-Hodgkin Lymphoma, as the Presentation of Occult Cancer, and With Cancer Therapies. 2018
ABIM/ACC Competency-Based Education Pilot in Internal Medicine and Cardiovascular Disease. 2017
Telomerase mRNA Reverses Senescence in Progeria Cells. 2017
Reply: Characteristic Left Ventricular Regional Wall Motion Abnormality Can Help Prevent Unnecessary Ischemic Workup. 2017
Reply: A Distinct Cardiomyopathy: HCN4 Syndrome Comprising Myocardial Noncompaction, Bradycardia, Mitral Valve Defects, and Aortic Dilation. 2017
Reply: Routine Ischemic Work-Up for Patients With New-Onset Heart Failure. 2017
¹⁸F-Sodium Fluoride PET/MR for the Assessment of Cardiac Amyloidosis. 2016
Cardio-Oncology: The Carney Complex Type I. 2016
"Off-Hours" Versus "On-Hours" Presentation in ST-Segment Elevation Myocardial Infarction: CHAMPION PHOENIX Findings. 2016
Reply: CABG Versus PCI: Are All Revascularization Strategies Created Equal? 2016
Investigator-Reported Bleeding Versus Post Hoc Adjudication of Bleeding: Lessons From the CHAMPION PHOENIX Trial. 2016
Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic Obstruction. 2015
Functional 3D printed patient-specific modeling of severe aortic stenosis. 2014
Reply: The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: more questions than answers? 2014
Left bundle branch block in non-ST-segment elevation acute coronary syndromes. Incidence, angiographic characteristics, and clinical outcomes. 2013
Prevalence of J-point elevation in families with sudden arrhythmic death syndrome. 2012
Is computed tomographic angiography prognostic in patients with cardiac symptoms? 2008
Follow-up of robotically assisted left ventricular epicardial leads for cardiac resynchronization therapy. 2005
Black pearl in the LIFE study: angiotensin-II receptor blockade on atrial fibrillation for future personalized medicine. 2005
Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction. 2005
Thrombolysis should be regarded as first-line therapy for prosthetic valve thrombosis in the absence of contraindications. 2005
Transcatheter intracardiac device implantation for atrial level defects and thrombosis: a call for randomized, controlled data. 2004
Exercise release of cardiac natriuretic peptides is markedly enhanced when patients with coronary artery disease are treated medically by beta-blockers. 2004
2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference Report. 2021
President's Page: Restoring the Patient-Physician Relationship. 2012
President's page: working toward the triple aim in cardiovascular health care. 2012
Highlights of the 18th annual scientific sessions of the American Society of Echocardiography Seattle, Washington, June 16-20, 2007. 2007
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. 2007
Meeting highlights of the 17th annual scientific sessions of the American Society of Echocardiography. Baltimore, Maryland, June 3-7, 2006. 2006
Quality of care reigns supreme: cardiologists at the helm. 2005
Meeting highlights of the 15th annual Scientific Sessions of the American Society of Echocardiography: June 26 to 30, 2004. 2004
Task force 1: The ACCF and AHA codes of conduct in human subjects research. 2004
Task force 4: Appropriate clinical care and issues of "self-referral". 2004
Stable Coronary Artery Disease in the Age of Geriatric Cardiology.. 81. 2023
Drug-Coated Balloons in Peripheral Vascular Interventions: Leave No Trace and Walk Away?. 81. 2023
On-Treatment Hypertension Control in a Real-World Cohort: Lower Blood Pressure Remains Better.. 78. 2021
Refinements in Predicting In-Hospital Mortality Following PCI: The Science and Art of Competing Risk Analysis.. 78. 2021
The Tricuspid Valve: No Longer Forgotten But Still Not Well Understood.. 77. 2021
Cardiology Practice and Training Post-COVID-19: Achieving "Normalcy" After Disruption.. 76. 2020
Framingham General Cardiovascular Risk Score and Cognitive Impairment: The Power of Foresight.. 75. 2020
Blood Pressure Ups and Downs Foreshadow Cerebral Microangiopathy.. 75. 2020
Aortic Dissection Risk in Marfan Syndrome.. 75. 2020
Statins and Cognitive Impairment: Not a Culprit, Protective in Some?. 74. 2019
Should Left Atrial Size Influence the Decision to Intervene in Degenerative Mitral Regurgitation?. 74. 2019
Carpal Tunnel Syndrome and Future Amyloidosis: Time to Heed the Warning Sign.. 74. 2019
Cardiac Magnetic Resonance and Cardio-Oncology: Does T₂ Signal the End of Anthracycline Cardiotoxicity?. 73. 2019
Time to Get Going on Involving FITs in Clinical Trials.. 72. 2018
Mitral Annular Calcification: The Search for Safer Options.. 72. 2018
Novel Markers for Adverse Events in Atrial Fibrillation.. 72. 2018
Additional Arterial Conduits in Coronary Artery Bypass Surgery: Finally Coming of Age.. 71. 2018
Device Closure of Patent Foramen Ovale in Patients With Cryptogenic Stroke: The Tide Has Turned.. 71. 2018
Delayed Coronary Obstruction After TAVR: A Call for Vigilance.. 71. 2018
Sham-Controlled Trials for Coronary Interventions: Ethically Acceptable and Ethically Important.. 71. 2018
PFO and Migraine: The Blind Leading the Blinded.. 70. 2017
Diabetes Status and Graft Patency After Coronary Bypass Surgery: Is There a Diabetes Paradox?. 70. 2017
Once More Unto the Breach: A New Treatment Paradigm for Protein-Losing Enteropathy.. 69. 2017
Bleeding and Mortality With Dual Antiplatelet Therapy: The Rashomon Effect.. 69. 2017
The Specialty of Mitral Valve Repair. 2017
At Arm's Length: Radiation Safety During Radial Percutaneous Coronary Intervention.. 69. 2017
Should We Measure Biomarkers for Myonecrosis Before and After PCI?. 68. 2016
Blood Pressure Variability: Insights From "Big Data".. 68. 2016
Are Immature Platelets Growing Up?: Toward a New Marker of Antiplatelet Drug Resistance.. 68. 2016
Validation of the Bleeding Academic Research Consortium Bleeding Definition: Towards a Standardized Bleeding Score.. 67. 2016
Corin Levels in Patients With Acute MI: Do We Need More Tools for Risk Stratification?. 67. 2016
The Future From the Past: A Chance for Change.. 67. 2016
Integrated Measure for Atherogenic Lipoproteins in the Modern Era: Risk Assessment Based on Apolipoprotein B.. 67. 2016
Low-Gradient Severe Aortic Stenosis With Preserved Ventricular Function: Trust But Verify.. 66. 2015
Watching a Procedure Evolve: Sequential Findings From the TVT Registry.. 66. 2015
The Role of Peer Support in Attaining Ideal Cardiovascular Health: Peer Pressure and Prevention.. 67. 2015
Team-Based Care and Quality: A Move Toward Evidence-Based Policy.. 66. 2015
Expanding the Roster: Developing New Inhibitors of Intravascular Thrombosis.. 65. 2015
Ischemic mitral regurgitation: is mitral valve physiology moving from global to local?. 64. 2014
Sustainable Development goals and the future of cardiovascular health: a statement from the Global Cardiovascular Disease Taskforce.. 64. 2014
Unravelling the causes of reduced peak oxygen consumption in patients with cancer: complex, timely, and necessary.. 64. 2014
Calculating risks and benefits to help guide revascularization decisions: turning all available data into useful information.. 64. 2014
Antithrombotic regimens in patients with atrial fibrillation and coronary disease: optimizing efficacy and safety.. 62. 2013
President's page: the year in retrospect: becoming CardioSmarter.. 61. 2013
President's page: public reporting of cardiovascular care: an opportunity to shape the future.. 61. 2013
President's page: ACC councils, sections, and committees: where membership makes a difference.. 60. 2012
President's page: Lifelong learning in the digital age.. 60. 2012
The heart of the matter: Why the ACC has an international outreach.. 60. 2012
President's page: plan, do, study, act: a proven path to progress.. 60. 2012
Can polymorphisms predict response to antiarrhythmic drugs in atrial fibrillation?. 60. 2012
BOLD new directions in myocardial ischemia imaging-myocardial oxygenation assessment by cardiac magnetic resonance.. 59. 2012
Extra-aortic identifiers to guide genetic testing in familial thoracic aortic aneurysms and dissections syndromes: it is all about the company one keeps.. 60. 2012
President's page. The ACC in 2012: transforming cardiovascular care, step by step.. 59. 2012
Rhythm control for atrial fibrillation favorable outcomes or futile endeavor?. 58. 2011
Bringing it all together: integration of physiology with anatomy during cardiac catheterization.. 58. 2011
American industry and the U.S. Cardiovascular Clinical Research Enterprise an appropriate analogy?. 58. 2011
Patients with congenitally corrected transposition of the great arteries and systemic tricuspid valve regurgitation should be referred for surgical consultation as soon as the diagnosis of regurgitation is made.. 57. 2011
Metaiodobenzylguanidine imaging comes of age. A new arrow in the prognostic quiver for heart failure patients.. 55. 2010
Balloon pulmonary valvuloplasty, pulmonary regurgitation, and exercise capacity the good, the bad, and the not yet clear.. 55. 2010
The benefits of platelet glycoprotein IIb/IIIa receptor inhibition during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: drug-specific or class effect?. 53. 2009
Clopidogrel and calcium-channel antagonists: another drug-drug interaction for the ever-wary clinician?. 52. 2008
Critical determinants of limb ischemia.. 52. 2008
Repair of the congenitally bicuspid regurgitant aortic valve: a strategic advance.. 52. 2008
Will measuring vasodilator-stimulated phosphoprotein phosphorylation help us optimize the loading dose of clopidogrel?. 51. 2008
Defining and utilizing surrogates in the evaluation of coronary stents: what do we really want and need to know?. 51. 2008
Computed tomography coronary angiography as an anatomic basis for risk stratification: déjà vu or something new?. 50. 2007
Late ischemic events after clopidogrel cessation following drug-eluting stenting: should we be worried?. 48. 2006
Measuring troponin elevation after percutaneous coronary intervention: ready for prime time?. 48. 2006
President's page: New York 1952 to Atlanta 2006: celebrating the cardiovascular community.. 47. 2005
Left ventricular hypertrophy in hypertrophic cardiomyopathy: what's in a phenotype?. 44. 2004
Platelets, the cardiologist, and coronary artery disease: moving beyond aggregation.. 43. 2004
Convocation address: put your heart into ACC fellowship: a vision for growth and achievement.. 43. 2004
QT interval prolongation and prognosis: further validation of the quantitative approach to electrocardiography.. 43. 2004
Combination therapy for acute myocardial infarction: will it survive?. 41. 2003
Cardiac enzyme elevations after percutaneous coronary intervention: myonecrosis, the coronary microcirculation and mortality.. 35. 2000
The decision for revascularization in the 1990s: between a rock and an expert panel.. 29. 1997
How best to identify prognostically important left ventricular hypertrophy: a cut to the chase.. 29. 1997
Left ventricular geometry, pathophysiology and prognosis.. 25. 1995
Blood pressure reduction and recovery of stunned myocardium in the hypertrophied hypertensive heart.. 20. 1992
Percutaneous aortic valvuloplasty: off the bandwagon, again.. 20. 1992
Heart rate adjustment of ST segment depression: is the glass half empty or half full?. 19. 1992
Significance of increased left ventricular mass in isolated systolic hypertension of the elderly.. 17. 1991
The increasing complexity of assessing diastolic function from ventricular filling dynamics.. 17. 1991
Tilt table for the investigation of syncope: there is nothing simple about fainting.. 17. 1991
Toward a more complete understanding of left ventricular afterload.. 17. 1991
Percutaneous transluminal coronary angioplasty: is what we see what we get?. 16. 1990
Improving Terminology to Describe Coronary Artery Procedures: JACC Review Topic of the Week. 2021
NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification: JACC State-of-the-Art Review. 2021
Cardiovascular Risk in Patients With Psoriasis: JACC Review Topic of the Week. 2021
Post-Stroke Cardiovascular Complications and Neurogenic Cardiac Injury: JACC State-of-the-Art Review. 2020
Focused Transesophageal Echocardiography During Cardiac Arrest Resuscitation: JACC Review Topic of the Week. 2020
Randomized Trials in Cardiac Surgery: JACC Review Topic of the Week. 2020
Alzheimer's Disease and Vascular Aging: JACC Focus Seminar. 2020
Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week. 2019
Vascular Cognitive Impairment and Dementia: JACC Scientific Expert Panel. 2019
The Radial Artery for Percutaneous Coronary Procedures or Surgery? 2018
Status of Early-Career Academic Cardiology: A Global Perspective. 2017
The Choice of Conduits in Coronary Artery Bypass Surgery. 2015
Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology. 2015
Finding the Gatekeeper to the Cardiac Catheterization Laboratory: Coronary CT Angiography or Stress Testing? 2015
Headed in the right direction but at risk for miscalculation: a critical appraisal of the 2013 ACC/AHA risk assessment guidelines. 2014
Radial versus femoral access. 2013
Pre- and post-operative diastolic dysfunction in patients with valvular heart disease: diagnosis and therapeutic implications. 2013
Biomarkers of peripheral arterial disease. 2010
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. 2010
Combining antiplatelet and anticoagulant therapies. 2009
Cardiogenic and aortogenic brain embolism. 2008
Mechanical dyssynchrony in congestive heart failure: diagnostic and therapeutic implications. 2008
Early breast cancer therapy and cardiovascular injury. 2007
Insights into degenerative aortic valve disease. 2007
Resting heart rate in cardiovascular disease. 2007
Noninvasive cardiac imaging in patients with hypertrophic cardiomyopathy. 2006
Cardiac arrhythmias. 2006
Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update. 2004
34th Bethesda Conference: Task force #3--What is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis? 2003
Antioxidants, statins, and atherosclerosis. 2003
Phytoestrogens and cardiovascular health. 2000
A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials. 1999
Heart rate adjustment of ST segment depression and performance of the exercise electrocardiogram: a critical evaluation. 1995
A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. 1991
Artificial Intelligence for Cardiovascular Care - Part 1: Advances: JACC Review Topic of the Week. 2024
Artificial Intelligence in Cardiovascular Care - Part 2: Applications: JACC Review Topic of the Week. 2024
Antithrombotic Therapy for Patients Undergoing Cardiac Electrophysiological and Interventional Procedures: JACC State-of-the-Art Review. 2024
Management of Adults With Anomalous Aortic Origin of the Coronary Arteries: State-of-the-Art Review. 2023
Recurrent Events in Cardiovascular Trials: JACC State-of-the-Art Review. 2023
Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints. 2023
Comprehensive Management of ANOCA, Part 1-Definition, Patient Population, and Diagnosis: JACC State-of-the-Art Review. 2023
Comprehensive Management of ANOCA, Part 2-Program Development, Treatment, and Research Initiatives: JACC State-of-the-Art Review. 2023
Sex Differences in Thoracic Aortic Disease and Dissection: JACC Review Topic of the Week. 2023
Risk of Arrhythmic Death in Patients With Nonischemic Cardiomyopathy: JACC Review Topic of the Week. 2023
Combined Minimally Invasive Surgical and Percutaneous Catheter Ablation of Atrial Fibrillation: JACC Review Topic of the Week. 2023
Research Opportunities in the Treatment of Mitral Valve Prolapse: JACC Expert Panel. 2022
A Practical Approach to Left Main Coronary Artery Disease: JACC State-of-the-Art Review. 2022
Coronary Artery Bypass Surgery Without Saphenous Vein Grafting: JACC Review Topic of the Week. 2022
Pericardial Effusion Provoking Atrial Fibrillation After Cardiac Surgery: JACC Review Topic of the Week. 2022
Sex-Related Factors in Valvular Heart Disease: JACC Focus Seminar 5/7. 2022
Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7. 2022
Gerotechnology for Older Adults With Cardiovascular Diseases: JACC State-of-the-Art Review. 2020
Randomized Trials Versus Common Sense and Clinical Observation: JACC Review Topic of the Week. 2020
10 Recommendations to Enhance Recruitment, Retention, and Career Advancement of Women Cardiologists. 2019
Deprescribing in Older Adults With Cardiovascular Disease. 2019
Cardiac Phenotypes in Hereditary Muscle Disorders: JACC State-of-the-Art Review. 2018
Mobile Health Advances in Physical Activity, Fitness, and Atrial Fibrillation: Moving Hearts. 2018
Using Digital Health Technology to Better Generate Evidence and Deliver Evidence-Based Care. 2018
Domain Management Approach to Heart Failure in the Geriatric Patient: Present and Future. 2018
Improving Heart Failure Therapeutics Development in the United States: The Heart Failure Collaboratory. 2018
Use of Antiplatelet Therapy/DAPT for Post-PCI Patients Undergoing Noncardiac Surgery. 2017
Potent P2Y₁₂ Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized Trials. 2017
The Academic Medical System: Reinvention to Survive the Revolution in Health Care. 2017
The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease. 2016
Left Ventricular Noncompaction: A Distinct Genetic Cardiomyopathy? 2016
Cardiovascular Effects of the New Weight Loss Agents. 2016
The Mitral Valve in Obstructive Hypertrophic Cardiomyopathy: A Test in Context. 2016
Natural History, Diagnostic Approaches, and Therapeutic Strategies for Patients With Asymptomatic Severe Aortic Stenosis. 2016
Device Closure of Patent Foramen Ovale After Stroke: Pooled Analysis of Completed Randomized Trials. 2016
Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise. 2015
Transcatheter Therapies for the Treatment of Valvular and Paravalvular Regurgitation in Acquired and Congenital Valvular Heart Disease. 2015
COCATS 4 Task Force 15: Training in Cardiovascular Research and Scholarly Activity. 2015
The future of clinical research and the ACC: empowerment through registries, data, and our members. 2014
Pulmonary hypertension due to left heart diseases. 2013
Pulmonary hypertension in chronic lung diseases. 2013
Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends. 2013
President's page: cardiovascular imaging: a look to the past, present and future. 2012
Antithrombotics in acute coronary syndromes. 2009
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. 2009
Patent foramen ovale: current pathology, pathophysiology, and clinical status. 2005
Stress echocardiography: current methodology and clinical applications. 2005
Rationale and strategies for implementing community-based transfer protocols for primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. 2004
Percutaneous revascularization of chronic coronary occlusions: an overview. 1995
Remodeling and reparation of the cardiovascular system. 1992
Taking a Stand Against Air Pollution-The Impact on Cardiovascular Disease: A Joint Opinion from the World Heart Federation, American College of Cardiology, American Heart Association, and the European Society of Cardiology. 2021
Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic: From the North American Society Leadership. 2020
Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment. 2020
ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. 2010

VIVO Weill Cornell Medical College

Journal of the American College of Cardiology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)